Abstract:A long-term epidemiological genetic study was conducted in which all new patients were evaluated prospectively at the Foundation for Depression and Manic Depression and two Lithium/Affective Disorders clinics at the Columbia-Presbyterian Medical Center between the years of 1972 and 1978. All patients met Feighner, RDC and DSM III criteria for Major Depressive Disorder after initial clinical screening interviews and were further subtyped using the Fieve-Dunner 7-point criteria. All 604 probands and 90% of 2711 first-degree relatives were interviewed blindly by diagnosticians trained in the use of the SADS structured interview. Cumulative morbid risk in parents, siblings and children of 490 bipolar probands was 15.6 +/- 3% and 14.0 +/- 1.7% in the first-degree relatives of 114 unipolar probands. A number of biological and genetic marker studies were simultaneously performed on samples of the overall population. The enzymes catechol O-methyltransferase and dopamine beta-hydroxylase, and the dexamethasone suppression test (SDT) did not show any biological marker value for outpatients even though both enzymes were determined to have hereditability. The HLA system, monoamine oxidase and acetylcholinesterase segregated differently from normal controls in samples of the patient population. The positive association findings with monoamine oxidase and the HLA system conflicted with the positive findings of other investigators, leaving doubtful their biological marker value. Red cell acetylcholinesterase was found to be significantly lower in affective disorder patients than in controls. This positive association finding was recently replicated by Mathews et al. (1982) but needs further confirmation. Using 28 blood group markers, a prior association study between the trait defining susceptibility to affective disorder and the genetic marker was positive for haptoglobin GC, and properdinfactor B, confirming earlier findings. Using the sib-pair method on the remaining 25 blood groups revealed that none other than peptidase A showed significant linkage with affective disorder since one significant finding is expected by chance. We conclude from the overall morbid risk data and segregation analyses that bipolar manic-depressive illness is a spectrum disease inherited through a multifactorial mode of genetic transmission (which is not synonymous with polygenetic inheritance) with possible genetic heterogeneity and find no evidence for X-linkage. Additional studies with acetylcholinesterase, haptoglobin, GC, and properdin-factor B are needed to confirm their positive biological/genetic marker value suggested by our long-term epidemiological study.

Linkage Analysis of the D1 Dopamine Receptor Gene and Manic Depression in Six Families.

A linkage analysis between DTNBP1 gene and schizophrenia

A linkage study of N-Methyl-D-Aspartater receptor NR1 subunit gene and schizophrenia.

A Comprehensive Linkage Analysis of Chromosome 21q22 Supports Prior Evidence for A Putative Bipolar Affective Disorder Locus

Dystrobrevin- binding protein 1 gene in schizophrenia

A Linkage Analysis Between Schizophrenia And GRM3 Gene

A Linkage Study of N-Methyl-D-aspartate Receptor 2A Subunit Gene and Schizophrenia

A linkage study of schizophrenia candidate regions in a Chinese multiplex pedigree

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

A Linkage Analysis Between Obsessive Compulsive Spectrum Disorders and Candidate Genes of Group II Metabotropic Glutamate Receptor

[Linkage Analysis of Susceptibility Genes for Familial Schizophrenia on Chromosome 1 in Chinese Population].

No association between schizophrenia and homozygosity at the D3 dopamine receptor gene.

The genetics of schizophrenia: glutamate not dopamine?

Search for biological/genetic markers in a long-term epidemiological and morbid risk study of affective disorders

Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways

[Linkage Disequilibrium Analysis of Chromosome 22 and Schizophrenia in a Chinese Population].

[Association Analysis Between Dopamine D1 Receptor Gene and Symptom Quantitative Trait of Schizophrenia].

Exclusion of Close Linkage of Tourettes-Syndrome to D1-Dopamine Receptor

No association between alleles or genotypes at the dopamine transporter gene and schizophrenia.

The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum

A Human-D1 Dopamine Receptor Gene is Located on Chromosome-5 at Q35.1 and Identifies an Ecori Rflp